Company Profile

Caliper Life Sciences Inc (AKA: Caliper Technologies)
Profile last edited on: 3/27/19      CAGE:       UEI:

Business Identifier: Microfluidics ("lab on a chip") for research instrumentation and drug screening
Year Founded
1995
First Award
1998
Latest Award
1998
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

68 Elm Street
Hopkinton, MA 01748
   (508) 435-9500
   cust.support@caliperls.com
   www.caliperls.com
Location: Multiple
Congr. District: 04
County: Middlesex

Public Profile

Headquartered in Hopkinton, MA with R&D, operations and manufacturing facilities for LabChip® devices in Mountain View, CA. Caliper Life Sciences, Inc. had been a research tools company engaged in the sale of innovative and enabling products, services, and systems to academic, government and and biotech/pharmaceutical researchers worldwide. In February 2003, Caliper Technologies had been acquired by LB Acquisitions LLC. and was later acquired a second time in September 2011 by PerkinElmer. Caliper Life Sciences had provided molecular solutions for preclinical imaging as well as in vitro research and diagnostics. Products and services, assembled from a portfolio of microfluidics, automation, liquid handling, and molecular imaging technologies, addresses various pre-clinical drug discovery and development bottlenecks included LabChip drug discovery, profiling and separations systems; IVIS noninvasive imaging systems, reagents and animal models; and automation and liquid handling systems. The company also offered contract research and transgenic animal services, drug discovery and development services, product support, and validation services.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
250-500
Revenue Range
20M-50M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : CALP
IP Holdings
250-500

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1998 1 NIH $103,800
Project Title: Kinase Assays For Ultra High Throughput Drug Screening

Key People / Management

  Kevin Hrusovsky -- President

  Daniel Kisner -- former president

  Kshitij Modi

  Wallace Parce

Company News

There are no news available.